Previous research has found that unexplained weight loss is an early sign of Alzheimer's. Now a study involving 140 older adults (60+), of whom half had early-stage Alzheimer's disease, has revealed that it is not the overall weight or fat levels that are important, but the loss of lean mass (weight of an individual's bones, muscles and organs without body fat). This directly correlated with reductions in the volume of the whole brain and of white matter only, along with declines in cognitive performance. The finding is consistent with research suggesting that brain pathology contributes to a decline in body composition, perhaps by disrupting the regulation of energy metabolism and food intake, perhaps through behavioral changes (there is a strong association between loss of muscle mass and reductions in physical activity), or perhaps through a common underlying mechanism, such as inflammation.
Losing muscle mass early sign of Alzheimer’s
Reference
Burns, J. M., Johnson, D. K., Watts, A., Swerdlow, R. H., & Brooks, W. M. (2010). Reduced Lean Mass in Early Alzheimer Disease and Its Association With Brain Atrophy. Arch Neurol, 67(4), 428-433. Retrieved from http://archneur.ama-assn.org/cgi/content/abstract/67/4/428
Related News
Mental activity may protect against memory problems in MS
Memory and learning problems often occur in multiple sclerosis, but bewilderingly, are only weakly associated with the severity of the disease. A study involving 44 people around the age of 45 who had MS for an average of 11 years has found that those with a mentally active lifestyle had good scores on the tests of learning and memory even if they had higher amounts of brain damage. The findings suggest that, as with Alzheimer’s disease, 'cognitive reserve' protects against cognitive impairment.
Low vitamin D levels related to lower cognitive function in MS sufferers
A study involving 236 persons with multiple sclerosis has found that only 7% of those with secondary-progressive MS showed sufficient vitamin D in their blood, compared to 18.3% of patients with the less severe relapsing-remitting type, and that higher levels of vitamin D3 and its byproducts were associated with better scores on cognitive tests (especially reasoning and planning), and less brain atrophy and fewer brain lesions. Lower-than-normal vitamin D status is known to be associated with a higher risk of developing MS
Personality may influence brain shrinkage in aging
An imaging study involving 79 volunteers aged 44 to 88 has found lower volumes of gray matter and faster rates of decline in the frontal and medial temporal lobes of those who ranked high in neuroticism traits, compared with those who ranked high in conscientious traits. These are brain regions particularly affected by aging. The idea that this might occur derived from the well-established effects of chronic stress on the brain. This is the first study to investigate whether the rate and extent of cognitive decline with age is influenced by personality variables.
Specific hippocampal atrophy early sign of MCI & Alzheimer's
A three-year study involving 169 people with mild cognitive impairment has found that those who later developed Alzheimer's disease showed 10-30% greater atrophy in two specific locations within the hippocampus, the cornu ammonis (CA1) and the subiculum.
Frequent episodes of jet lag without sufficient recovery time may reduce cognitive function
A study of 20 flight attendants suggests that people who undergo repeated, frequent episodes of jet lag without sufficient recovery time between trips may develop actual tissue changes in the brain in an area that's involved in spatial orientation and related aspects of cognitive function. The extent to which this is due to sleep deprivation rather than time shifts per se is unknown. These findings may also be relevant to shift workers, medical trainees and others who work long hours.
Gene variation associated with brain atrophy in MCI
Submitted by Fiona McPherson
on
Analysis of data from 237 patients with mild cognitive impairment (mean age 79.9) has found that, compared to those carrying the ‘normal’ ApoE3 gene (the most common variant of the ApoE gene), the ApoE4 carriers showed markedly greater rates of shrinkage in 13 of 15 brain regions thought to be key components of the brain networks disrupted in Alzheimer’s.
http://www.eurekalert.org/pub_releases/2014-01/rson-gva010714.php
Coping with cognitive decline in MS
Cognitive impairment affects 40-65% of people with MS. Why? In the past year, a number of studies have helped us build a better picture of the precise nature of cognitive problems that may affect multiple sclerosis sufferers:
Omega 3 levels affect whether B vitamins can slow brain's decline
A study involving 266 people with mild cognitive impairment (aged 70+) has found that B vitamins are more effective in slowing cognitive decline when people have higher omega 3 levels.
Participants were randomly selected to receive either a B-vitamin supplement (folic acid, vitamins B6 and B12) or a placebo pill for two years. The vitamins had little to no effect for those with low levels of omega-3 fatty acids, but were very effective for those with high baseline omega-3 levels.
Genes linked to Alzheimer's
Five new risk genes for Alzheimer's disease
Genetic data from more than 94,000 individuals has revealed five new risk genes for Alzheimer's disease, and confirmed 20 known others. The new genes are: IQCK, ACE, ADAM10, ADAMTS1 and WWOX.
The findings support developing evidence that groups of genes associated with specific biological processes, such as cell trafficking, lipid transport, inflammation and the immune response, are "genetic hubs" that are an important part of the disease process.
Vascular health linked to dementia risk
Optimal levels of cardiovascular health in older age associated with lower dementia risk
A French study involving 6,626 older adults (65+) found that having optimal levels in more measures of cardiovascular health (nonsmoking, weight, diet, physical activity, cholesterol, blood glucose and blood pressure) was associated with lower dementia risk and slower rates of cognitive decline. Dementia risk and rates of cognitive decline lowered with each additional metric at the recommended optimal level.